Springbok Capital Management »

Inozyme Pharma shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $478k 62k 7.66

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Brighthouse Finl (BHF)
Bio Rad Labs Cl A (BIO)
Baidu Spon Adr Rep A (BIDU)
Pioneer Natural Resources
Hess (HES)
Microsoft Corporation (MSFT)
Overstock (BYON)
Netease Sponsored Ads (NTES)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Springbok Capital Management

Top funds holding Inozyme Pharma

Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
Samlyn Capital
BlackRock
Affinity Asset Advisors
Vanguard Group
NEA Management Company
Millennium Management
Samsara BioCapital
Sphera Funds Management
Geode Capital Management
Saturn V Capital Management
Blue Owl Capital Holdings

View all funds holding Inozyme Pharma